Yoshihisa Tokumaru

34PUBLICATIONS
34CO-AUTHORS
Communications engineering not elsewhere classifiedPredictive and prognostic markersElectrometallurgyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 13, 2026
Correction: Tokumaru et al. High Expression of microRNA-143 Is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 3213.

|Aug 11, 2026
Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells.

|Sep 22, 2025
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer.

Manabu Futamura, Yasuko Nagao, Yukiko Takai

|Jul 11, 2025
Application of N-NOSE for Evaluating the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Yoshihisa Tokumaru, Yoshimi Niwa, Ryutaro Mori

|Jul 24, 2023
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).

Manabu Futamura, Takahiro Nakayama, Tetsuhiro Yoshinami

|Jan 07, 2023
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).

Manabu Futamura, Kazuhiro Ishihara, Yasuko Nagao

Pageof 6

Frequent Collaborators

28 joint publications

Kazuaki Takabe

20 joint publications

Masanori Oshi

6 joint publications

Manabu Futamura

5 joint publications

Eriko Katsuta